Team Andrew Weinberg's Fundraising Page

Although there have been major therapeutic advancements in pediatric cancer care over the last several decades, cancer remains one of the most common causes of childhood death.  In 1994, my son Andrew was diagnosed with rhabdomyosarcoma, a rare form of muscle tumor.    Despite aggressive treatment at Dana-Farber, he passed away shortly before his third birthday.

With the generous support of family and friends, the Medicinal Chemistry Group of the Northeastern Section of the American Chemical Society and the Dana-Farber Cancer Institute, a fund was created in 1995 and endowed in 2001.  The Andrew H. Weinberg Memorial Endowment Fund supports an annual Symposium that brings researchers together from the field of chemotherapy development with those in the biomedical research and clinical care communities at large, helping to foster an environment for synergy and originality in cancer research.